— Know what they know.
Not Investment Advice
Also trades as: 000028.SZ (SHZ) · $vol 9M

200028.SZ SHZ

China National Accord Medicines Corporation Ltd.
1W: +0.0% 1M: +0.6% 3M: +1.9% YTD: -14.6% 1Y: -10.8% 3Y: -8.3% 5Y: -16.2%
HK$11.98 ($1.53)
+0.04 (+0.34%)
 
SHZ · Healthcare · Medical - Distribution · Tech Score Sell · Power 36 · HK$12.7B mcap · 238M float · 0.062% daily turnover
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market CapHK$12.7B ($1.6B)
52W Range11.5-12.81
Volume38,210
Avg Volume147,572
Beta0.11
DividendHK$0.71
Analyst Ratings
No analyst coverage
Company Info
CEOZhaoxiong Lin
Employees39,449
SectorHealthcare
IndustryMedical - Distribution
IPO Date1993-08-10
Yizhi Pharmaceutical Building
Shenzhen, GD 518029
CN
86 755 2587 5140
About China National Accord Medicines Corporation Ltd.

China National Accord Medicines Corporation Ltd. focuses on the distribution of medical supplies and pharmaceuticals. Its broad product range encompasses traditional Chinese, biochemical, biological, and diagnostic medicines, as well as antibiotics and chemical preparations. The company also trades in food products, industrial chemicals, various general commodities, medical apparatus and instruments, glassware, cosmetics, daily merchandise, and offers wholesale and retail of health products. In addition to product sales, it provides a suite of services, including freight transportation, warehousing, loading and unloading, professional consultation, goods agency, technology import and export, and property leasing. As of December 31, 2021, the company operated a significant retail network of 8,798 drugstores, consisting of 7,257 directly owned and 1,541 franchised outlets, spanning 20 provinces, autonomous regions, and municipalities across China. Founded in 2004 and headquartered in Shenzhen, China, this entity functions as a subsidiary of Sinopharm Group Co., Ltd.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms